Greenlane Holdings Inc.

10/30/2024 | Press release | Distributed by Public on 10/30/2024 06:46

Material Agreement Form 8 K

Item 1.01. Entry into a Material Definitive Agreement

On October 29, 2024, Greenlane Holdings, Inc. (the "Company') entered into a series of agreements in order to restructure existing senior debt. The Company and its senior lenders entered into the agreements described below to extend the maturity and reduce the amount of such debt.

Exchange Agreement

On October 29, 2024,the Company entered into an Exchange Agreement (the "Exchange Agreement") with its Senior Subordinated Lender, whereby the Company agreed to exchange an aggregate of $4,617,307 of debt originally owed to Agile Capital Funding LLC and Cedar Advance LLC in a 3(a)(9) exchange for new Senior Subordinated Notes in the principal amount of $4,000,000 due one year from issuance (the "Exchange Note"), reducing outstanding indebtedness by approximately $617,000. The Exchange Note is convertible at the option of the holder at $3.17 per share. In connection with the Exchange, the Company issued an aggregate of 1,261,830 five year warrants with an exercise price of $3.04 per share (the "Exchange Warrants").

In addition, pursuant to the terms of the Exchange Agreement, the Company agreed to issue warrants to the Holders, with an initial exercise price of $3.04, exercisable 180 days after issuance (the "Exchange Inducement Warrants"). The Exchange Inducement Warrants were issued to incentivize the holders to exercise some or all of their existing warrants originally issued on August 13, 2024 (the "Existing Warrants") for cash, which existing warrants have an exercise price of $2.50 per share. The Exchange Inducement Warrants are initially exercisable for zero shares, but to the extent that the Holders exercise any of such Existing Warrants during the one-hundred sixty day inducement period, the Exchange Inducement Warrants will become exercisable on April 30, 2025 for 200% of the number of Existing Warrants exercised for cash during such inducement period.

Also, pursuant to the Exchange Agreement, the Senior Subordinated Lender agreed that it will exercise its Existing Warrants for cash prior to exercising any of its outstanding pre-funded warrants, contingent on the market price of the common stock being above $2.50 per share and certain other conditions. The above agreement will terminate upon the Company receiving certain cash proceeds and prepaying at least $2,250,000 of Cobra's Notes.

The Company engaged Aegis Capital Corp. ("Aegis") to act as its exclusive placement agent in connection with the transactions summarized above and will pay Aegis a cash fee equal to 4.0% of the aggregate gross proceeds from the exercise of the Existing Warrants. No fees were paid to Aegis by the Company in connection with the restructuring of debt described above.

The Exchange Agreement is filed as Exhibit 10.1. The Exchange Note is filed as Exhibit 10.2. The Exchange Warrant is filed as Exhibit 10.3. The Exchange Inducement Warrant is filed as Exhibit 10.4. The descriptions of the Exchange Agreement, the Exchange Notes, the Exchange Warrants and the Exchange Inducement Warrants are qualified by the actual agreements filed as Exhibits hereto.

First Amendment to Amended and Restated Secured Promissory Note

On October 29, 2024, the Company entered into the First Amendment to Amended and Restated Secured Promissory Note (the "Note Amendment") with Cobra Alternative Capital Strategies LLC ("Cobra"). Pursuant to the Note Amendment, Cobra agreed to extend the Maturity Date of its senior promissory note dated May 1, 2024, which is currently due. The new Maturity Date will be October 29, 2025. In consideration for the extension, the Company (i) agreed to make such Notes convertible at the option of Cobra with a conversion price of $3.17 per share, (ii) agreed to prepay Cobra's debt with 50% of any money raised by the Company from warrant exercise proceeds and from capital raise transactions, and (iii) issued Cobra an aggregate of 500,000 five year warrants with an exercise price of $3.04 per share which are identical to the Exchange Warrants.

The description of the Note Amendment is a summary and is qualified by the actual agreement which is filed as Exhibit 10.5 hereto.